Solventum (NYSE:SOLV) Upgraded by Wall Street Zen to “Buy” Rating

by · The Cerbat Gem

Wall Street Zen upgraded shares of Solventum (NYSE:SOLV – Free Report) from a hold rating to a buy rating in a research note released on Saturday morning.

A number of other equities research analysts have also issued reports on SOLV. Zacks Research lowered Solventum from a “strong-buy” rating to a “hold” rating in a research report on Monday, December 1st. BTIG Research upgraded shares of Solventum from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a research report on Tuesday, December 2nd. Wells Fargo & Company raised their price target on shares of Solventum from $79.00 to $82.00 and gave the stock an “equal weight” rating in a research report on Monday, September 15th. Piper Sandler raised their target price on shares of Solventum from $94.00 to $98.00 and gave the company an “overweight” rating in a report on Friday, November 7th. Finally, UBS Group reissued a “neutral” rating on shares of Solventum in a report on Friday, November 21st. Four investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $87.00.

Check Out Our Latest Stock Analysis on Solventum

Solventum Stock Up 0.2%

SOLV opened at $82.96 on Friday. Solventum has a twelve month low of $60.70 and a twelve month high of $88.20. The firm’s 50-day simple moving average is $75.96 and its 200-day simple moving average is $74.40. The company has a debt-to-equity ratio of 1.03, a quick ratio of 1.14 and a current ratio of 1.50. The firm has a market cap of $14.39 billion, a price-to-earnings ratio of 9.56, a PEG ratio of 8.76 and a beta of 0.26.

Solventum (NYSE:SOLV – Get Free Report) last announced its earnings results on Thursday, November 6th. The company reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.43 by $0.07. The company had revenue of $2.10 billion during the quarter, compared to the consensus estimate of $2.05 billion. Solventum had a net margin of 18.13% and a return on equity of 28.01%. The company’s revenue was up .7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.64 earnings per share. Solventum has set its FY 2025 guidance at 5.980-6.080 EPS. Equities research analysts anticipate that Solventum will post 6.58 EPS for the current fiscal year.

Solventum declared that its board has authorized a stock repurchase program on Thursday, November 20th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the company to purchase up to 7.5% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s board believes its shares are undervalued.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Allworth Financial LP grew its holdings in Solventum by 2.8% during the 3rd quarter. Allworth Financial LP now owns 4,788 shares of the company’s stock valued at $350,000 after buying an additional 129 shares in the last quarter. CIBC Private Wealth Group LLC grew its position in Solventum by 0.5% during the third quarter. CIBC Private Wealth Group LLC now owns 24,710 shares of the company’s stock worth $1,804,000 after buying an additional 134 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd increased its stake in Solventum by 0.7% in the 2nd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 19,778 shares of the company’s stock worth $1,500,000 after acquiring an additional 140 shares during the last quarter. BOKF NA increased its position in shares of Solventum by 6.9% during the 3rd quarter. BOKF NA now owns 2,193 shares of the company’s stock valued at $160,000 after purchasing an additional 141 shares during the last quarter. Finally, Tradition Wealth Management LLC lifted its stake in Solventum by 1.6% in the first quarter. Tradition Wealth Management LLC now owns 8,830 shares of the company’s stock worth $671,000 after purchasing an additional 143 shares during the last quarter.

Solventum Company Profile

(Get Free Report)

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

See Also